Submit Deal

Argot Partners

Summary

Edit Data

Argot Partners is a strategic communications firm focused on the life sciences.

Market Context

Deals Overview

Edit Data

Total Deals47

Valued Deals35

Total Value£13,871M

Avg. Deal Size£396M

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Ranked Teams

Ranked Individuals

Deals (47)

Dealmakers

United States

Biotechnology

target

Crescent Biopharma

bidder

GLYCOMIMETICS

value n/a

11 dealmakers

United States

Biotechnology

target

Bluejay Therapeutics

bidder

Arkin Bio Ventures

£145m

2 dealmakers

United States

Biotechnology

target

Zenas Biopharma

bidder

Federated Hermes

£160m

2 dealmakers

United States

Biotechnology

target

Deciphera Pharmaceuticals

bidder

Ono Pharmaceutical

£1,920m

57 dealmakers

United States

Biotechnology

target

Alterome Therapeutics

bidder

Goldman Sachs Asset Management

£105m

6 dealmakers

United States

Biotechnology

target

Homology Medicines

bidder

Q32 Bio

£92m

12 dealmakers

United States

Biotechnology

target

Cartesian Therapeutics

bidder

Selecta Biosciences

value n/a

22 dealmakers

United States

Biotechnology

target

Lung Therapeutics

bidder

Aileron Therapeutics

value n/a

8 dealmakers

United States

Biotechnology

target

Mariana Oncology

bidder

Deep Track Capital

£139m

5 dealmakers

United States

Biotechnology

target

ABCURO

bidder

Redmile Group

£121m

17 dealmakers

United States

Biotechnology

target

Neoleukin Therapeutics

bidder

Neurogene

£282m

6 dealmakers

United States

Biotechnology

target

Travere Therapeutics (bile Acid Product Portfolio)

bidder

Mirum Pharmaceuticals

£366m

32 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy